QUOIN PHARMACEUTICALS, LTD.
Profile
Company Names
QUOIN PHARMACEUTICALS, LTD.
CELLECT BIOTECHNOLOGY LTD.
Addresses
42127 PLEASANT FOREST COURT, ASHBURN, VA 20148
AZRIELI CENTER, ROUND TOWER, 30TH FL., 132 MENACHEM BEGIN BLVD., TEL AVIV, L3 6701101
23 HATA-AS STREET, KFAR SABA, L3 41444
Phone Numbers
(703) 980-4182
+972 58-448-8821
972 99741444
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
ISRAEL
Total Amount Raised:
$113,750,626.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-10-14
$105,254,891.00
$105,254,891.00
$0.00
Equity
3
2022-08-23
$193,537.00
$193,537.00
$0.00
Equity
2
2018-01-31
$3,999,996.00
$3,999,996.00
$0.00
1
2017-09-11
$4,302,202.00
$4,303,000.00
$798.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL
BERELOWITZ
DIRECTOR
DAVID
BRAUN
DIRECTOR
PIMCO ABSOLUTE RETURN STRATEGY V ONSHORE FUND LLC
| PIMCO ELEVEN POINT FUND, LP
| PHFS IV SP, A SEGREGATED PORTFOLIO OF PHFS SERIES SPC
| PIMCO CORPORATE OPPORTUNITIES FUND II ONSHORE FEEDER, L.P.
| PIMCO CORPORATE OPPORTUNITIES FUND II, L.P.
| PIMCO CORPORATE OPPORTUNITIES FUND II OFFSHORE FEEDER, L.P.
| PHFS V SP, A SEGREGATED PORTFOLIO OF PHFS SERIES SPC
| PHFS III EQUITY DISPERSION OFFSHORE FUND, L.P.
| CELLECT BIOTECHNOLOGY LTD.
JAMES
CULVERWELL
DIRECTOR
DAVID
GROSSMAN
DIRECTOR
GUIDE-LINK, INC.
| YAPP MEDIA, LLC
| FIRST BOSTON BRIDGE LENDING POOL I, LLC
| ADVANCED INHALATION THERAPIES (AIT) LTD.
| AIT THERAPEUTICS, INC.
| CELLECT BIOTECHNOLOGY LTD.
| PUSH WELLNESS SOLUTIONS, INC.
| READYSTATE PARTNERS, LP
| READYSTATE OFFSHORE FUND, LTD.
| READYSTATE F10 I LP
| READYSTATE STRATEGIC OPPORTUNITIES PARTNERS LP
DENNIS
LANGER
DIRECTOR
DICERNA PHARMACEUTICALS INC
| LIGHT SCIENCES ONCOLOGY INC
| INNOCOLL HOLDINGS, INC.
| SANCILIO + COMPANY, INC.
| ALZHEON, INC.
| SANCILIO PHARMACEUTICALS COMPANY, INC.
| MYRIAD GENETICS INC
| QUOIN PHARMACEUTICALS, INC.
| NEXEOS DIAGNOSTICS, INC.
| BROOKLYN IMMUNOTHERAPEUTICS, INC.
| QUOIN PHARMACEUTICALS, LTD.
| AVICENNA BIOSCIENCES, INC.
| EMPIRICO INC.
MICHAEL
MYERS
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-10-14
D
PHARMACEUTICALS
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
DECLINE TO DISCLOSE
Equity
2022-08-23
D
PHARMACEUTICALS
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
NO REVENUES
2018-01-31
D
PHARMACEUTICALS
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841]
NO REVENUES
2017-09-11
